RESMED INC — Director's Dealing 2023

Nov 20, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2023-11-16

Reporting Person: Drexler Karen (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-16	ResMed Common Stock	A	884	—	Acquired	8871	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-16	ResMed Common Stock Options	$148.90	A	2575	Acquired	2030-11-16	ResMed Common Stock (2575)	Direct

Footnotes

F1: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2024, or the annual shareholder's meeting in the year following the grant date.

F2: Represents the date options become exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.